Document is current
Any future updates will be listed below
-
Authors
Conteduca, Vincenza https://orcid.org/0000-0002-6921-714X
Di Tullio, Piergiorgio
Allamprese, Rossana https://orcid.org/0009-0004-0901-0894
Bruno, Giuseppina
Lolli, Cristian
Schepisi, Giuseppe https://orcid.org/0000-0002-9973-4869
Rosano, Aldo https://orcid.org/0000-0002-5453-2294
Giordano, Guido
Garofoli, Marianna
Chiuri, Vincenzo Emanuele
Fratino, Lucia
Zanardi, Elisa https://orcid.org/0000-0002-3252-4226
Galli, Luca
Massari, Francesco
Falagario, Ugo https://orcid.org/0000-0002-1152-3005
Rescigno, Pasquale
Fornarini, Giuseppe https://orcid.org/0000-0003-4754-6572
Sanguedolce, Francesca
Santini, Daniele
Procopio, Giuseppe
Caffo, Orazio https://orcid.org/0000-0001-7968-2531
Carrieri, Giuseppe
Landriscina, Matteo
De Giorgi, Ugo
- License Information
-
More Information
Article History
Received: 29 July 2023
Revised: 22 January 2024
Accepted: 23 January 2024
First Online: 12 February 2024
Competing interests
: VC has served as a consultant/advisory board member for Janssen, Astellas, Merck, AstraZeneca, Amgen, EISAI, Recordati, Novartis, Ipsen and Bayer and has received speaker honoraria or travel support from Astellas, Janssen, Ipsen, Bayer, Gilead and Bristol Myers Squibb. PR served as an advisory board for MSD and AstraZeneca Italy. FM has received research support and/or honoraria from Astellas, BMS, Janssen, Ipsen, MSD and Pfizer. GF served as an advisory board member for Astellas, Janssen, Pfizer, Bayer, MSD, Merck and received travel accommodation from Astellas, Janssen, Bayer. GP served as a consultant and/or a speaker for Bayer, BMS, Novartis, Amgen, Pfizer, Janssen, Ipsen, Boehringer. OC served as an advisory/board member of AAA, AstraZeneca, Astellas, Bayer, Janssen, Ipsen, MSD, Pfizer, and has received speaker honoraria from Ipsen, MSD, AstraZeneca, Astellas, Janssen. UDG served as an advisory/board member of Astellas, Bayer, BMS, IPSEN, Janssen, Merck, Pfizer, Sanofi, received research grant/funding to the institution from AstraZeneca, Roche, Sanofi and travel/accommodations/expenses from BMS, IPSEN, Janssen, Pfizer. No potential conflicts of interest were disclosed by the other authors.
